Global Lymphedema Treatment Market (2022 to 2030) - Share, Size, Trends, Industry Analysis Report - ResearchAndMarkets.com
DUBLIN--(BUSINESS WIRE)--The "Lymphedema Treatment Market Share, Size, Trends, Industry Analysis Report, By Treatment Type, By Affected Area, By End-User , By Region; Segment Forecast, 2022 - 2030" report has been added to ResearchAndMarkets.com's offering.
The global Lymphedema treatment market size is expected to reach USD 1,735.36 million by 2030 according to a new study. The report gives a detailed insight into current market dynamics and provides analysis on future market growth.
- AIROS Medical Inc.
- Avet Pharmaceuticals Inc.
- Bio-compression Systems
- Cardinal Health
- Convatec Inc.
- Essity (BSN medical GmbH)
- Huntleigh Healthcare Limited
- Koya Medical
- Lohmann & Rauscher
- Medi GmbH
- Mego Afek ltd.
- PAUL HARTMANN
- SIGVARIS GROUP
- Smith+Nephew HERANTIS PHARMA Plc
- Tactile medical
The increasing number of individuals being affected by Lymphedema is anticipated to drive the growth of the Lymphedema cure industry. Additionally, with the growing prevalence of the disease, innovative and advanced treatments are being developed in order to minimize risk during cure are also surging. Furthermore, the increasing healthcare expenditure coupled with the growing innovation across the healthcare sector is further projected to drive the industry growth. In addition, the launch of new medical devices by pharmaceutical companies is also fueling industry growth across the globe.
Based on the type, the secondary Lymphedema segment is dominating the global industry and is anticipated to lead the industry over the forecasting period. Secondary Lymphedema is generally caused by damage to the Lymph system via cancer treatment through radiation therapy and surgery among others. According to the CDC (Centers for Disease Control & Prevention), the majority of the patients suffer from secondary Lymphedema. Thus, the presence of a large patient pool is anticipated to drive the growth of the segment.
The rising investment by government and private pharmaceutical companies towards R&D for drug discovery is anticipated to present huge industry growth opportunities. Additionally, the growing prevalence of cancer and other chronic diseases is anticipated to drive the growth of the industry. For instance, as per the International Agency for Research on Cancer (IARC), in 2018, there were nearly 17.0 million new cancer cases were recorded, which is likely to grow to 27.5 million new cancer cases by 2040 because of the growth and aging of the population. Thereby, the rising occurrence of cancer is further acts as catalyzing factor for the market growth.
Key Topics Covered:
2. Executive Summary
3. Research Methodology
4. Global Lymphedema Treatment Market Insights
4.1. Lymphedema Treatment - Industry Snapshot
4.2. Lymphedema Treatment Market Dynamics
4.2.1. Drivers and Opportunities
188.8.131.52. Prevalence of lymphedema and cancer
184.108.40.206. Technological advancements in diagnostic imaging modalities
4.2.2. Restraints and Challenges
220.127.116.11. Short half-life of radiopharmaceuticals
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of Suppliers (Moderate)
4.3.2. Threats of New Entrants: (Low)
4.3.3. Bargaining Power of Buyers (Moderate)
4.3.4. Threat of Substitute (Moderate)
4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Lymphedema Treatment Market Industry Trends
4.6. Value Chain Analysis
4.7. COVID-19 Impact Analysis
5. Global Lymphedema Treatment Market, by Treatment Type
6. Global Lymphedema Treatment Market, by Affected Area
7. Global Lymphedema Treatment Market, by End-Use
8. Global Lymphedema Treatment Market, by Geography
9. Competitive Landscape
9.1. Expansion and Acquisition Analysis
10. Company Profiles
For more information about this report visit https://www.researchandmarkets.com/r/nq4dyf.
Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900